Literature DB >> 29526631

A methodological review of induced animal models of autoimmune diseases.

Xinhua Yu1, Frank Petersen2.   

Abstract

Autoimmune disorders are characterized by a loss of immune tolerance and consequent autoimmunity-mediated disease manifestation. Experimental models are invaluable research tools helping us to understand disease pathogenesis and to search for novel therapeutics. Animal models of autoimmune diseases consist of two groups, spontaneous and induced models. In this review article, we focus on the induced models of autoimmune diseases. Due to the complex nature of autoimmune disorders, many strategies have been applied for the induction of corresponding experimental models in animals like monkeys, rabbits, rats, and mice. Methodologically, these strategies can be categorized into three categories, namely immunization with autoantigen, transfer of autoimmunity, and induction by environmental factors. In this review article, we aim to provide a comprehensive overview of the field of induced experimental autoimmune diseases. On the one hand, we describe and summarize the different strategies used for induction of experimental autoimmune disease. On the other hand, we discuss how to select a strategy for modeling human disease, including the choice of an appropriate species and method for such an approach.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29526631     DOI: 10.1016/j.autrev.2018.03.001

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  7 in total

1.  Standardization of Antigen-Emulsion Preparations for the Induction of Autoimmune Disease Models.

Authors:  Louise M Topping; Laura Romero-Castillo; Vilma Urbonaviciute; Hans Bolinsson; Felix I Clanchy; Rikard Holmdahl; B Thomas Bäckström; Richard O Williams
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

Review 2.  Mouse Models of Alopecia Areata: C3H/HeJ Mice Versus the Humanized AA Mouse Model.

Authors:  Amos Gilhar; Rimma Laufer Britva; Aviad Keren; Ralf Paus
Journal:  J Investig Dermatol Symp Proc       Date:  2020-11

3.  Gene Expression Profiling of Lacrimal Glands Identifies the Ectopic Expression of MHC II on Glandular Cells as a Presymptomatic Feature in a Mouse Model of Primary Sjögren's Syndrome.

Authors:  Junping Yin; Junfeng Zheng; Fengyuan Deng; Wenjie Zhao; Yan Chen; Qiaoniang Huang; Renliang Huang; Lifang Wen; Xiaoyang Yue; Frank Petersen; Xinhua Yu
Journal:  Front Immunol       Date:  2018-10-31       Impact factor: 7.561

4.  Abrogation of self-tolerance by misfolded self-antigens complexed with MHC class II molecules.

Authors:  Hui Jin; Kazuki Kishida; Noriko Arase; Sumiko Matsuoka; Wataru Nakai; Masako Kohyama; Tadahiro Suenaga; Ken Yamamoto; Takehiko Sasazuki; Hisashi Arase
Journal:  Sci Adv       Date:  2022-03-04       Impact factor: 14.136

5.  Both T and B cells are indispensable for the development of a PBMC transfer-induced humanized mouse model for SSc.

Authors:  Yaqing Shu; Xiaoyang Yue; Jacqueline Wax; Brigitte Kasper; Junping Yin; Xiaoqing Wang; Liang Zhang; Marjan Ahmadi; Harald Heidecke; Antje Müller; Peter Lamprecht; Xinhua Yu; Gabriela Riemekasten; Frank Petersen
Journal:  Arthritis Res Ther       Date:  2022-08-25       Impact factor: 5.606

Review 6.  Recent Advances in Mouse Models of Sjögren's Syndrome.

Authors:  Yunzhen Gao; Yan Chen; Zhongjian Zhang; Xinhua Yu; Junfeng Zheng
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

7.  Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL/6 mice that reproduces fibrosis, vasculopathy and autoimmunity.

Authors:  Walcy Rosolia Teodoro; Zelita Aparecida de Jesus Queiroz; Lais Araujo Dos Santos; Sergio Catanozi; Antonio Dos Santos Filho; Cleonice Bueno; Margarete B G Vendramini; Sandra de Morais Fernezlian; Esmeralda M Eher; Percival D Sampaio-Barros; Sandra Gofinet Pasoto; Fernanda Degobbi T Q S Lopes; Ana Paula Pereira Velosa; Vera Luiza Capelozzi
Journal:  Arthritis Res Ther       Date:  2019-12-11       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.